Profarma Distribuidora de Produtos Farmacêuticos S.A. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was BRL 2,297.55 million compared to BRL 2,037.75 million a year ago. Net income was BRL 32.16 million compared to BRL 16.33 million a year ago. Basic earnings per share from continuing operations was BRL 0.262 compared to BRL 0.133 a year ago. Diluted earnings per share from continuing operations was BRL 0.262 compared to BRL 0.133 a year ago.
For the nine months, sales was BRL 6,454.71 million compared to BRL 5,720.47 million a year ago. Net income was BRL 41.98 million compared to BRL 76.31 million a year ago. Basic earnings per share from continuing operations was BRL 0.342 compared to BRL 0.622 a year ago. Diluted earnings per share from continuing operations was BRL 0.342 compared to BRL 0.622 a year ago.